Full-Time

Scientist I

Translational Sciences

Confirmed live in the last 24 hours

Tr1X

Tr1X

11-50 employees

Develops cellular immunotherapies for autoimmune diseases

Biotechnology
Healthcare

Compensation Overview

$120k - $135kAnnually

Mid, Senior

No H1B Sponsorship

San Diego, CA, USA

Category
Bioinformatics
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis

You match the following Tr1X's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • MS + 4 years of industry experience, or PhD with experience in immunology, cell biology, or related fields, and conducting bioanalytical assay development.
  • At least 2 years of experience in a translational/biomarker setting.
  • Extensive experience in cell-based assays to characterize T cells, using immunological techniques such as flow cytometry, multi-plexed immunoassays (e.g., MSD, ELISA), and molecular techniques (e.g., RNAseq, Nanostring, dPCR), ideally supporting clinical trial sample analysis.
  • Strong ability to critically analyze data, optimize assays independently, and collaborate effectively within a team, with excellent verbal and written communication skills.
  • Impeccable documentation skills, including timely electronic lab notebook entries.
  • Strong attention to detail to detect experimental anomalies and artifacts.
  • Ability to write technical documents such as SOPs and qualification reports, and adhere to SOP specifications without deviation.
  • Ability to work under tight deadlines, manage multiple tasks, and drive them to completion.
  • The disposition to thrive in a fast-paced startup environment with an agile and organized mindset.
  • To be able to safely conduct experiments while wearing required PPE.
Responsibilities
  • Develop cell-based and molecular bioanalytical methods to interrogate biomarkers of diseases and responses to therapy.
  • Execute clinical sample processing and report reproducible results.
  • Analyze large amount of data real-time and present findings at team/departmental meetings.
  • Evaluate various protocols and methodologies in support of clinical studies.
  • Collaborate to ensure seamless transfer of assays and knowledge between teams and personnel.
  • Contribute to the development of biomarker and translational strategies.
  • Maintain detailed and highly organized documentation of experimental procedures.
Desired Qualifications
  • Prior experience with assay qualification and/or validation.
  • Knowledge of GxP / Quality systems / Compliance Framework for translational activities.
  • Prior experience working with partner labs/CROs and transferring assays.

Tr1X focuses on developing cellular immunotherapies aimed at treating autoimmune and inflammatory diseases. The company uses a proprietary platform to create cell therapy products that help rebalance the immune system and restore balance within the body, which can lead to long-term tolerance of the immune response. Unlike many other companies in the biopharmaceutical sector, Tr1X specializes in first-in-class therapies that target the underlying issues of immune dysfunction rather than just managing symptoms. The goal of Tr1X is to provide advanced therapeutic solutions that improve the quality of life for patients suffering from these challenging conditions.

Company Stage

Series A

Total Funding

$73M

Headquarters

San Diego, California

Founded

2018

Growth & Insights
Headcount

6 month growth

0%

1 year growth

2%

2 year growth

2%
Simplify Jobs

Simplify's Take

What believers are saying

  • FDA clearance for TRX103 IND boosts Tr1X's credibility and market potential.
  • $75M Series A funding supports rapid development of Tr1X's therapies.
  • Growing autoimmune therapeutics market offers significant opportunities for Tr1X's products.

What critics are saying

  • Emerging competition in allogeneic Treg therapy could impact Tr1X's market share.
  • High manufacturing costs may pose financial risks for Tr1X.
  • Regulatory hurdles could delay Tr1X's product development and market entry.

What makes Tr1X unique

  • Tr1X uses a proprietary platform for novel cellular immunotherapies.
  • The company focuses on allogeneic regulatory T-cell therapies for autoimmune diseases.
  • Tr1X's TRX103 is the first allogeneic engineered Tr1 regulatory T cell product.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

401(k) Company Match

Flexible Work Hours

Stock Options

Performance Bonus